52.00
0.00
(0.00%)
As of January 15 at 2:36:16 PM GMT+8. Market Open.
Key Executives
Key Executives Information Not Available
TCI GENE Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
TCI GENE Inc. provides precision preventive medicines in Taiwan. It offers genetic testing for nutrient metabolism and weight management; G2 and ACE2 genetic testing; supplements; skin care, antiaging, kids' growth, and Alzheimer disease products; and serum for DNA types. The company also provides nutrition consultation services. TCI GENE Inc. is based in Taipei, Taiwan.
Corporate Governance
TCI GENE Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
November 6, 2023 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
6744.TWO Feng Chi Biotech Corp.
19.70
0.00%
6999.TWO Han Biomedical
36.00
+3.79%
6652.TWO Eusol Biotech Co.,Ltd.
7.60
-2.56%
6945.TWO AP Biosciences Inc
51.10
-2.48%
7808.TWO BIONET TX Corp
46.00
-1.08%
7729.TWO SBI
20.40
-3.55%
4170.TWO VBI
14.10
+0.71%
4197.TWO Visgeneer Inc.
9.78
0.00%
7790.TWO SSLab
70.70
-1.53%
6917.TWO Andros Pharmaceuticals Co.,Ltd
18.20
+0.55%